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TNF-alpha recruits CFTR into lipid rafts in MDCK cells 
S. Huang, T. Dudez, B. St ant on, G. Lukacs, S. Suter, M. Chanson 
Geneva University Hospitals, Geneva, Switzerlarul 
We have shown that CFFR is required for activation of the tyr osine kinase c Src in 
airway epithelial cell lines exposed to TNF alpha. To understand the molecular 
mechanisms that l ink CFFR to c Src, we investigated whether CFTR is present in 
cholester ol~enriched membrane micr odomain lipid rafts. Lipid rafts, which serve as 
platforms for efficient signal transduction i  a number of cell systems, have been 
shown to contain c Src. Lipid rafts were isolated from MI)CKI  or MI)CKI I  cells 
expressing GFP tagged wi ld type CFFR by density gradient ultr acentrifugation and 
Western blots. CFTR was detected in non soluble fractions using antibodies against 
CFTR or GFP. Quality of the preparation was confirmed by the detection of lipid 
raft markers, such as caveolin 1, f lolt i l in 1 as wel l  as the tyr osine kinases c Src and 
c Yes. The amount of CFTR in lipid rafts, which represented about 10% of total 
CFTR, was reduced by extraction of cell surface cholesterol with cyclodextrin and 
increased by depolymerization of actin f i laments with latrunculin. Interestingly, 
exposure of MI )CKI  or MI)CKI I  cells to TNF alpha increased the proportion of c 
Src and CFFR present in lipid rafts. CFFR, however, was not recovered in 
membrane microdomains from MI )CK  cells expressing a truncated CFTR lacking 
its four last c terminal amino acids (DTRL), exposed or not to TNF alpha. The data 
indicate that in two expression cell systems, CFFR containing lipid rafts are 
dynamic structures that might be stabilized by the cytoskeleton via PDZ binding 
domain's protein interaction, and that this interaction can be modulated by pro 
inflammatory mediators. 
Supported by the Swiss Nat ional  Science Foundation mad Vaincre la  
Mucoviscidose. 
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Immunological detecSon of human CFTR after gene transfer to the 
lung 
A. Wilson, H. Davidson, S.T. Cooper, G. McLachlan, D.J. Porteous, A.C. Boyd 
Medical Sciences (Medical Genetics), Univemity of Edinburgh, EH4 2XU, UK arul 
UK Cystic Fibrosis Gene Therapy Consortium 
Our aim is to use the sheep as a model to refine immtmobist cehemical (IHC) assays 
to detect transgenic human CFTR (hCFTR) ha patients treated by gene therapy. 
Nasal brusbings (NBs) from F508del/F508del patients have fewer cells with 
apically lcealised CF IR  compared to normal brusbings. We have found that inter 
subject variation is so high that measuring the efficacy of CF gene therapy by 
simply counting cells with apical hCFTR may be problematic. Here we explore 
another approach. 
NB cells from humans and sheep were harvested, fixed and cytospun onto glass 
slides. Sections were cut from frozen samples of sheep lung and airways, then f ixed 
in formaldehyde mad sucrose before IHC. 
Human NB cells were examined using dilutions of G449 (an antibody which does 
not detect ovine CFTR): at 1:600 the apical signal was found to be just visible. 
Sections from airways of sheep aerosolised using a polymer/bCFl'R plasmid 
complex were doubly labelled with G449 at 1:6(~, and the antibody MATG1061 
(which detects both CFTRs) at various dilutions. At  its usual dilution (1:1CO), 
MATG1061 labelled many cells, but was found to label only G449 positive cells at 
1:250. 
The monospecificity of G449 allowed us to identify hCFTR4ransfected cells in 
sheep. With this information, we  determined the dilution at which MATG1061 
detects cells expressing hCFTR, but not he ovine CFTR background. This method 
permits the optimisation of dilution conditions for CFTR antibodies that may then 
be used to specifically detect transgenic hCFTR expression in the airways of 
patients treated with CF gene therapy. 
We thank the CF Trust for support, and Hugo de Jonge, Angus Nairn and Transggne 
for generous gitts of antibody. 
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Inhibition by TNF-alpha and IL-4 of cationic lipid mediated gene 
kansfer in cystic fibrosis tracheal gland cells 
S. Bast oner o, M. Gargouri, S. Or tiou, J.L. Gu~ant, M.D. Met  ten 
Laboratoire de Pathologic CeIlulaire et MoIdculaire n Nutrition. Equipe INSERM 
U 724, Facultd de mddecine, PB I84, 54505 l/8ndoeuvre-I~s-Nancy, France 
Background: In vivo, tracheal gland serous cells highly express the fi~Jstic Fibrosis 
Tr ansmembr ane conductance R gulator (cfir) gene. This gene is mutated ha the letal 
monogenic disease C'y st ic Fibrosis (CF). Clinical trials in which the cfir cDNA was 
delivered to the respiratory epithel ia of CF patients have resulted in modest, 
transient gene expression and yet no improvement of their cl inical status. 
Metku)ds arm results: As CF is characterized by mucus inspissation, airway 
infection, and severe inflammation, we  tested the hypothesis that hff lammation and 
especially two cytokines involved in the Th l /Th2  i lff lammatory response, 
hater leuldn 4 (IL~i) and TNFc~ could inhibit gene transfer efficiency using a model 
of human CF tracheal gland serous cells (CF KM4) and Lipofectamine r agent as a 
vector. The specific secretory defects of CF KM4 cells were cotlected by 
lipofectamine mediated cfir gene transfer. However, this was altered when cells 
were pre treated with IL~i and TNFcc Expression of lucifer ase reporter gene by IL 
4 and TNFc~ pre treated CF KM4 cells was measured by activity and real~ime RT 
PCR. Both cytokines induced similar mad synergistic hahibition of transgene 
expression and activity. This cytokine mediated hahibition could be prevented by 
anti i lfflammatory agents uch as glucccorticoids but not by non steroidal (NSAI) 
agents. 
Conclusions: This data s~aggests hat an hfflammatory context generated by IL~i 
and TNFc~ can inhibit cfir gene transfer ha CF tracheal gland serous cells and that 
glucccorticoids may have a protecting action. 
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Tight junction regulation and AAV-2 mediated gene kansfer in a 
cystic fibrosis airway epithelial cell line 
N. Make~e va, O. For sberg, N. Welsh, G.M. Roomans 
Department ofMedical Ceil Biology, University of Uppsala, Sweden 
Virus mediated gene therapy is one possible approach to treatment of cystic 
fibrosis. Adeno associated viruses (AAV) may be relatively suitable vectors. 
However, airway epithel ium is resistant to infection by AAV 2 when the virus is 
applied to the luminal  surface of the cells. A possible strategy for enhancing ene 
transfer is to modify the paracellular permeability, thereby permitting the diffusion 
of vectors to the basolateral surface, where uptake receptors are expressed. 
The effect of different substances on paracellular permeability ha a monolayer 
culture of CF airway epithelial cells (CFBE41o cells) was investigated by 
measuring the tr ansepithelial electrical resistance (TEER). CFBFAlo cells reached 
a stable TEER of about 800 f2cm 2 after 9 13 days in culture. Sodium caprate (C 10) 
very rapidly reduced TEER, mad with 20 or 30 mM C10 levels of 1CO f2cm ~ mad 
below were reached alter 1 2 minutes. With EGTA about one hour is needed to 
reduce TEER to these levels. Also high concentrations of NaCI (202.5 raM) and D 
marmitol (405 mM) reduce TEER but not to the same extent as C10. 
AAV 2 transfer to the epithelial cells was determined using the Lac Z gene as a 
reporter gene. Treatment with C10 resulted in a considerable and concentration 
dependent enhancement of AAV 2 LacZ gene transfer. At  20 mM C 10 60% of the 
cells, and at 30 mM C10 90% of the cells were tr ansfected. EGTA, D mamaitol mad 
NaCI showed very little efficiency in enhancing gene transfer. One major concem 
was, however, the induction of cell death by the different TJ regulating agents. 
The results indicate that C10 may be a better agent for enhancing ene transfer than 
EGTA, D mamaitol and NaCI and suggest hat AAV 2 can be a suitable vector for 
gene transfer tbrough the basolateral membrane. 
